This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned
Advertisement
Articles by This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
3
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5